Volume 9 Issue 5
Sep.  2018
Turn off MathJax
Article Contents
Yu Tao, Chen Wen, Liu Zhijia, et al. Effect of common immunosuppressants on Tfr cells and Breg cells[J]. ORGAN TRANSPLANTATION, 2018, 9(5): 360-364,404. doi: 10.3969/j.issn.1674-7445.2018.05.007
Citation: Yu Tao, Chen Wen, Liu Zhijia, et al. Effect of common immunosuppressants on Tfr cells and Breg cells[J]. ORGAN TRANSPLANTATION, 2018, 9(5): 360-364,404. doi: 10.3969/j.issn.1674-7445.2018.05.007

Effect of common immunosuppressants on Tfr cells and Breg cells

doi: 10.3969/j.issn.1674-7445.2018.05.007
More Information
  • Corresponding author: Shi Bingyi, Email: shibingyi666@126.com
  • Received Date: 2018-07-24
    Available Online: 2021-01-19
  • Publish Date: 2018-09-15
  •   Objective  To investigate the effect of common immunosuppressants on the follicular regulatory T cells (Tfr cells) and regulatory B cells (Breg cells).  Methods  Peripheral blood samples were collected from 6 healthy volunteers (5 mL per case).The lymphocytes were isolated by human lymphocyte isolation solution and cultured.The cells were divided into the control group (without supplement of immunosuppressants), ciclosporin group (250 ng/mL), tacrolimus group (10 ng/mL) and sirolimus group (10 ng/mL).The cells were stimulated with corresponding immunosuppressants for 48 h, respectively.The proportion of Breg and Tfr cells in the lymphocytes in each group was detected by flow cytometry.The content of interleukin (IL)-21 in the supernatants of each group was detected by enzyme-linked immunosorbent assay (ELISA).  Results  Compared with the control group, the proportion of Breg cells in the lymphocytes in the ciclosporin, tacrolimus and sirolimus groups was all significantly increased (all P < 0.05).In the ciclosporin group and tacrolimus group, the proportion of Tfr cells in the lymphocytes was both significantly elevated (both P < 0.05), whereas the proportion of Tfr cells in the lymphocytes in the sirolimus group was significantly decreased (P < 0.05).ELISA demonstrated that compared with the control group, the IL-21 content in the supernatants in the ciclosporin and tacrolimus groups was both significantly decreased (both P < 0.05).Use of sirolimus exerted no significant effect upon the secretion of IL-21 (P > 0.05).  Conclusions  Ciclosporin and tacrolimus can inhibit the immune response of B cells.

     

  • loading
  • [1]
    LOUPY A, DUONG VAN HUYEN JP, HIDALGO L, et al.Gene expression profiling for the identification and classification of antibody-mediated heart rejection[J].Circulation, 2017, 135(10):917-935.DOI: 10.1161/CIRCULATIONAHA.116.022907.
    [2]
    SVOBODOVA E, GAZDIC T, KUBANEK M, et al.Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance[J].Transpl Int, 2016, 29(1):63-72.DOI: 10.1111/tri.12684.
    [3]
    SZAFLIK JP, MAJOR J, IZDEBSKA J, et al.Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty:a 2-year follow-up study[J].Graefes Arch Clin Exp Ophthalmol, 2016, 254(2):307-314.DOI: 10.1007/s00417-015-3200-2.
    [4]
    BONNEAU E, TÉTREAULT N, ROBITAILLE R, et al.Metabolomics:perspectives on potential biomarkers in organ transplantation and immunosuppressant toxicity[J].Clin Biochem, 2016, 49(4/5):377-384.DOI: 10.1016/j.clinbiochem.2016.01.006.
    [5]
    ALOULOU M, CARR EJ, GADOR M, et al.Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells[J].Nat Commun, 2016, 7:10579.DOI: 10.1038/ncomms10579.
    [6]
    WU H, CHEN Y, LIU H, et al.Follicular regulatory T cells repress cytokine production by follicular helper T cells and optimize IgG responses in mice[J].Eur J Immunol, 2016, 46(5):1152-1161.DOI: 10.1002/eji.201546094.
    [7]
    MAVROPOULOS A, SIMOPOULOU T, VARNA A, et al.Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis[J].Arthritis Rheumatol, 2016, 68(2):494-504.DOI: 10.1002/art.39437.
    [8]
    LAL G, KULKARNI N, NAKAYAMA Y, et al.IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance[J].Immunol Lett, 2016, 170:52-63.DOI: 10.1016/j.imlet.2016.01.002.
    [9]
    YE Q, WANG Z, LI Y, et al.The effect of anti-TfR mouse/human chimeric antibody on anti-transplant rejection[J].Transpl Int, 2011, 24(2):167-174.DOI: 10.1111/j.1432-2277.2010.01155.x.
    [10]
    FOLEY J F. Why rapamycin is a good immunosuppressant[J].Science, 2016, 352(6290):1185-1187.DOI: 10.1126/science.352.6290.1185-q.
    [11]
    ESKANDARY F, BOND G, KOZAKOWSKI N, et al.Diagnostic contribution of donor-specific antibody characteristics to uncover late silent antibody-mediated rejection-results of a cross-sectional screening study[J].Transplantation, 2017, 101(3):631-641.DOI: 10.1097/TP.0000000000001195.
    [12]
    HAAS M, MIROCHA J, REINSMOEN NL, et al.Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies[J].Kidney Int, 2017, 91(3):729-737.DOI: 10.1016/j.kint.2016.10.040.
    [13]
    RAMESSUR CHANDRAN S, HAN Y, TESCH GH, et al.Inhibition of spleen tyrosine kinase reduces renal allograft injury in a rat model of acute antibody-mediated rejection in sensitized recipients[J].Transplantation, 2017, 101(8):e240-e248.DOI: 10.1097/TP.0000000000001826.
    [14]
    FARO A, WEYMANN A.Transplantation[J].Pediatr Clin North Am, 2016, 63(4):709-734.DOI: 10.1016/j.pcl.2016.04.010.
    [15]
    CROZE LE, TETAZ R, ROUSTIT M, et al.Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies[J].Transpl Int, 2014, 27(8):775-783.DOI: 10.1111/tri.12330.
    [16]
    DHAEZE T, HELLINGS N.Circulating follicular regulatory T cells in autoimmune diseases and their waning in multiple sclerosis[J].Crit Rev Immunol, 2016, 36(6):511-522.DOI: 10.1615/CritRevImmunol.2017019850.
    [17]
    ZHU Y, ZOU L, LIU YC.T follicular helper cells, T follicular regulatory cells and autoimmunity[J].Int Immunol, 2016, 28(4):173-179.DOI: 10.1093/intimm/dxv079.
    [18]
    SHIPMAN L.Systemic lupus erythematosus:compromised pDC-BREG cell crosstalk[J].Nat Rev Rheumatol, 2016, 12(5):253.DOI: 10.1038/nrrheum.2016.43.
    [19]
    SAGE PT, SHARPE AH.T follicular regulatory cells[J].Immunol Rev, 2016, 271(1):246-259.DOI: 10.1111/imr.12411.
    [20]
    XU L, HUANG Q, WANG H, et al.The kinase mTORC1 promotes the generation and suppressive function of follicular regulatory T cells[J].Immunity, 2017, 47(3):538-551.DOI: 10.1016/j.immuni.2017.08.011.
    [21]
    BORATYŃSKA M, SMOLSKA D.Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders[J].Transpl Int, 2008, 21(6):605-608.DOI: 10.1111/j.1432-2277.2008.00655.x.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)

    Article Metrics

    Article views (184) PDF downloads(22) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return